Ipsen's First Focus Is Endocrinology As Firm Moves Toward Specialty Care
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
As Ipsen shifts away from an emphasis on primary care and toward specialty care therapies – a move straight out of Big Pharma’s playbook – endocrinology will become a pillar of its specialty care pipeline.